Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Juni 2026 07:00 ET | Quelle: VERAXA Biotech GmbH

VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026

VERAXA Biotech AG (NASDAQ: VRXA) has generated new in vitro proof-of-concept data validating its novel BiTAC-ADC technology platform.
15. Juni 2026 16:30 ET | Quelle: Custom Market Insights

Bio-Based Cosmetics and Personal Care Ingredients Market Size/Share Worth USD 18.93 Billion by 2035 at a 11.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT)

Austin, TX, USA, June 16, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Bio-Based Cosmetics and Personal Care Ingredients Market Size, Trends and...
02. März 2026 08:00 ET | Quelle: Jupiter Neurosciences, Inc.

Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026

Advancing FDA-Cleared Phase IIa Parkinson’s Program Targeting Neuroinflammation Dual-Path Strategy Combines Clinical Development with Revenue-Generating Nugevia™ JUPITER, FL, March 02, 2026 (GLOBE...
11. Dezember 2025 08:08 ET | Quelle: Bleichmar Fonti & Auld

MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action

MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action
29. November 2025 06:38 ET | Quelle: Bleichmar Fonti & Auld

MLTX STOCK: Lose Money on Your MoonLake Immunotherapeutics Investment? Contact BFA Law about the Pending Securities Class Action before December 15 Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
27. November 2025 07:18 ET | Quelle: Bleichmar Fonti & Auld

MLTX INVESTMENT: MoonLake Immunotherapeutics Investors with Losses may have Rights in Securities Class Action – Contact BFA Law by December 15 Deadline

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
25. November 2025 08:33 ET | Quelle: Bleichmar Fonti & Auld

INVESTOR REMINDER: Important MoonLake Immunotherapeutics Securities Class Action Deadline Approaching on December 15 for Investors with Losses – Contact BFA Law

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
23. November 2025 07:38 ET | Quelle: Bleichmar Fonti & Auld

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
17. November 2025 08:08 ET | Quelle: Bleichmar Fonti & Auld

MLTX STOCK LOSS: MoonLake Immunotherapeutics Faces Securities Fraud Class Action due to Drug Trial Results – Contact BFA Law if You Suffered Losses

MoonLake Immunotherapeutics investors that lost money are notified to contact BFA before the December 15, 2025 securities fraud class action deadline.
23. Oktober 2025 17:24 ET | Quelle: kneat.com, inc.

Kneat to Announce 2025 Third-Quarter Financial Results November 12, 2025

Kneat to release Q3 2025 financial results on November 12, 2025, host earnings call November 13, 2025.

Nächste Seite